Corticosteroids and risk of hospitalization for infection among cancer patients treated with programmed cell death receptor/ligand 1 (PD-1/PD-L1) inhibitors

被引：0
|
作者：
Sorup, Signe [1 ]
Darvalics, Bianka [1 ]
Russo, Leo [2 ]
Oksen, Dina [3 ]
Lamy, Francois-Xavier [3 ]
Verpillat, Patrice [3 ]
Sorensen, Henrik T. [1 ]
Cronin-Fenton, Deirdre [1 ]
机构：
[1] Aarhus Univ, Aarhus, Denmark
[2] Pfizer, Collegeville, PA USA
[3] Merck KGaA, Darmstadt, Germany
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2019年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
912
引用
收藏
页码：442 / 443
页数：2
相关论文
共 50 条
  • [31] Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics
    Cassol, Clarissa A.
    Owen, Dwight
    Kendra, Kari
    Braga, Juarez R.
    Frankel, Wendy L.
    Arnold, Christina A.
    HISTOPATHOLOGY, 2020, 77 (02) : 240 - 249
  • [32] Targeting Programmed Cell Death-1 (PD-1) and Ligand (PD-L1): A new era in cancer active immunotherapy
    Constantinidou, Anastasia
    Alifieris, Constantinos
    Trafalis, Dimitrios T.
    PHARMACOLOGY & THERAPEUTICS, 2019, 194 : 84 - 106
  • [33] Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
    Gatalica, Zoran
    Snyder, Carrie
    Maney, Todd
    Ghazalpour, Anatole
    Holterman, Daniel A.
    Xiao, Nianqing
    Overberg, Peggy
    Rose, Inga
    Basu, Gargi D.
    Vranic, Semir
    Lynch, Henry T.
    Von Hoff, Daniel D.
    Hamid, Omid
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (12) : 2965 - 2970
  • [34] Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis
    Levy, Dylan A.
    Patel, Jaimin J.
    Nguyen, Shaun A.
    Jungbauer, W. Nicholas
    Neskey, David M.
    Cohen, Ezra E. W.
    Paulos, Chrystal M.
    Kaczmar, John A.
    Knochelmann, Hannah M.
    Day, Terry A.
    WORLD JOURNAL OF OTORHINOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 8 (03): : 177 - 186
  • [35] Programmed death 1 (PD-1) and ligand (PD-L1) inhibitors in head and neck squamous cell carcinoma: A meta-analysis
    Levy Dylan A.
    Patel Jaimin J.
    Nguyen Shaun A.
    Jungbauer W. Nicholas
    Neskey David M.
    Cohen Ezra E. W.
    Paulos Chrystal M.
    Kaczmar John A.
    Knochelmann Hannah M.
    Day Terry A.
    世界耳鼻咽喉头颈外科杂志英文版, 2022, 08 (03) : 177 - 186
  • [36] Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1
    Guzik, Katarzyna
    Zak, Krzysztof M.
    Grudnik, Przemyslaw
    Magiera, Katarzyna
    Musielak, Bogdan
    Torner, Ricarda
    Skalniak, Lukasz
    Domling, Alexander
    Dubin, Grzegorz
    Holak, Tad A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5857 - 5867
  • [37] Gene expression of programmed cell death (PD-1) and its ligand, PD-L1, in primary epithelial ovarian cancer
    Talukdar, S.
    Cepela, J.
    Chang, Z.
    Zhang, Y.
    Grad, A.
    Mullany, S. A.
    Starr, T.
    Winterhoff, B.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 254 - 254
  • [38] Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
    Ba, Yilmaz
    Koc, Nermin
    Helvac, Kaan
    Kocak, Cem
    Akdeniz, Rasit
    Sahin, Havva Hande Keser
    TRANSLATIONAL ONCOLOGY, 2021, 14 (02):
  • [39] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
    Tamura, A.
    Yoshida, M.
    Yamamoto, N.
    Nakamura, S.
    Fujiwara, T.
    Tahara, T.
    Saito, A.
    Kozaki, A.
    Kishimoto, K.
    Ishida, T.
    Hasegawa, D.
    Kosaka, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
  • [40] Herpes zoster in lung cancer patients treated with PD-1/PD-L1 inhibitors
    Taoka, Masataka
    Ochi, Nobuaki
    Yamane, Hiromichi
    Yamamoto, Takenobu
    Kawahara, Tatsuyuki
    Uji, Emiko
    Kosaka, Youko
    Takeda, Kouhei
    Nagasaki, Yasunari
    Nakanishi, Hidekazu
    Aoyama, Yumi
    Takigawa, Nagio
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (03) : 456 - 462
12345